secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2026-06-22T10:05:49+00:00
Accession:  0001213900-26-070316
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive stockholders re-elect three directors and ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- Directors elected: Dr. Shalabh Gupta (8.13M for, 174k withhold), Dr. Sandeep Laumas (7.70M for, 610k withhold), D. Sarawati Kenkare-Mitra (7.51M for, 795k withhold).
- Ratification of Grassi & Co. as auditor for FY 2026 passed with 14.67M for, 287k against, 10k abstentions.
- 14,964,159 shares represented at the meeting, constituting a quorum.
- Broker non-votes totaled approximately 6.66M shares on each director election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/0001213900-26-070316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390026070316/ea0295382-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-070316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer